Letermovir Prophylaxis Is Effective for Cytomegalovirus Reactivation after Allogeneic Hematopoietic Cell Transplantation: Single Center Real-World Data

被引：0
|
作者：
Derigs, Patrick [1 ]
Schubert, Maria-Luisa [1 ]
Schnitzler, Paul [2 ]
Mueller-Tidow, Carsten [1 ]
Luft, Thomas [1 ]
Dreger, Peter [1 ]
Schmitt, Michael [1 ]
机构：
[1] Univ Heidelberg Hosp, Dept Internal Med Hematol Oncol Rheumatol 5, Heidelberg, Germany
[2] Heidelberg Univ Hosp, Dept Virol, Heidelberg, Germany
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-125675
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5650
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Efficacy of Letermovir for Prophylaxis of CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Multi Center Retrospective Analysis among Japanese Patients
    Mori, Yasuo
    Yoshimoto, Goichi
    Eto, Tetsuya
    Nagafuji, Koji
    Iwasaki, Hiromi
    Ito, Yoshikiyo
    Ohno, Yuju
    Kamimura, Tomohiko
    Ogawa, Ryosuke
    Numata, Akihiko
    Kato, Koji
    Takenaka, Katsuto
    Miyamoto, Toshihiro
    Akashi, Koichi
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 469 - 470
  • [42] Real-World Efficacy and Safety of Letermovir Prophylaxis in Adolescent Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: A Single Center Observational Study
    Xu, Ziwei
    Wang, Huafang
    BLOOD, 2024, 144 : 7330 - 7330
  • [43] Versatile Effects of Letermovir Prophylaxis for Cytomegalovirus on Allogeneic Hematopoietic Stem Cell Transplantation: A single-institution Analysis
    Jinnouchi, Fumiaki
    Katayama, Yuta
    Imanaka, Ryota
    Terasaki, Tatsuya
    Nunomura, Takuya
    Okatani, Takeshi
    Kyo, Kohei
    Itagaki, Mitsuhiro
    Katsutani, Shinya
    Muta, Tsuyoshi
    Asaoku, Hideki
    Iwato, Koji
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 492 - 493
  • [44] Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis
    Kampouri, Eleftheria
    Zamora, Danniel
    Kiem, Erika S.
    Liu, Winnie
    Ibrahimi, Sarah
    Blazevic, Rachel L.
    Lovas, Erika A.
    Kimball, Louise E.
    Huang, Meei-Li
    Jerome, Keith R.
    Oshima, Masumi Ueda
    Mielcarek, Marco
    Zerr, Danielle M.
    Boeckh, Michael J.
    Krantz, Elizabeth M.
    Hill, Joshua A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (11) : 1450.e1 - 1450.e7
  • [45] Letermovir for Cytomegalovirus prophylaxis in pediatric hematopoietic stem cell transplantation
    Chen, Teaghan T.
    David, Alexandria P.
    Barthelmess, Erin K.
    MacBrayne, Christine E.
    PEDIATRIC BLOOD & CANCER, 2024, 70 (11)
  • [46] Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience
    Gill, Jessica
    Stella, Davide
    Dogliotti, Irene
    Dellacasa, Chiara
    Giaccone, Luisa
    Busca, Alessandro
    HEMATO, 2023, 4 (02): : 158 - 169
  • [47] Comment on: Letermovir for Cytomegalovirus prophylaxis in pediatric hematopoietic cell transplantation
    Styczynski, Jan
    PEDIATRIC BLOOD & CANCER, 2023, 70 (12)
  • [48] Letermovir prophylaxis reduces the risk for CMV reactivation after allogeneic stem cell transplantation
    Koch, K.
    Herhaus, P.
    Osswald, L.
    Braitsch, K.
    Bassermann, F.
    Verbeek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 62 - 62
  • [49] Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation
    Zhang, Shijia
    Shanley, Ryan
    Weisdorf, Daniel J.
    Rashidi, Armin
    BLOOD ADVANCES, 2020, 4 (12) : 2640 - 2643
  • [50] CMV REACTIVATION AFTER STOPPING LETERMOVIR PRIMARY PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS
    Chavaz, Lara
    Royston, Lena
    Masouridi-Levrat, Stavroula
    Mamez, Anne-Claire
    Giannotti, Federica
    Morin, Sarah
    Van Delden, Christian
    Chalandon, Yves
    Neofytos, Dionysios
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 93 - 93
12345